Global and China Cancer Genome Sequencing Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Cancer Genome Sequencing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Second generation
  • 1.2.3 Third generation
• 1.3 Market by Application
  • 1.3.1 Global Cancer Genome Sequencing Market Share by Application: 2020 VS 2026
  • 1.3.2 Treatment
  • 1.3.3 Research
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Cancer Genome Sequencing Market Perspective (2015-2026)
• 2.2 Global Cancer Genome Sequencing Growth Trends by Regions
  • 2.2.1 Cancer Genome Sequencing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Cancer Genome Sequencing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Cancer Genome Sequencing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Cancer Genome Sequencing Players by Market Size
  • 3.1.1 Global Top Cancer Genome Sequencing Players by Revenue (2015-2020)
  • 3.1.2 Global Cancer Genome Sequencing Revenue Market Share by Players (2015-2020)
• 3.2 Global Cancer Genome Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Cancer Genome Sequencing Revenue
• 3.4 Global Cancer Genome Sequencing Market Concentration Ratio
  • 3.4.1 Global Cancer Genome Sequencing Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Cancer Genome Sequencing Revenue in 2019
• 3.5 Key Players Cancer Genome Sequencing Area Served
• 3.6 Key Players Cancer Genome Sequencing Product Solution and Service
• 3.7 Date of Enter into Cancer Genome Sequencing Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Genome Sequencing Breakdown Data by Type (2015-2026)

• 4.1 Global Cancer Genome Sequencing Historic Market Size by Type (2015-2020)
• 4.2 Global Cancer Genome Sequencing Forecasted Market Size by Type (2021-2026)

5 Cancer Genome Sequencing Breakdown Data by Application (2015-2026)

• 5.1 Global Cancer Genome Sequencing Historic Market Size by Application (2015-2020)
• 5.2 Global Cancer Genome Sequencing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Cancer Genome Sequencing Market Size (2015-2026)
• 6.2 North America Cancer Genome Sequencing Market Size by Type (2015-2020)
• 6.3 North America Cancer Genome Sequencing Market Size by Application (2015-2020)
• 6.4 North America Cancer Genome Sequencing Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Cancer Genome Sequencing Market Size (2015-2026)
• 7.2 Europe Cancer Genome Sequencing Market Size by Type (2015-2020)
• 7.3 Europe Cancer Genome Sequencing Market Size by Application (2015-2020)
• 7.4 Europe Cancer Genome Sequencing Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Cancer Genome Sequencing Market Size (2015-2026)
• 8.2 China Cancer Genome Sequencing Market Size by Type (2015-2020)
• 8.3 China Cancer Genome Sequencing Market Size by Application (2015-2020)
• 8.4 China Cancer Genome Sequencing Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Cancer Genome Sequencing Market Size (2015-2026)
• 9.2 Japan Cancer Genome Sequencing Market Size by Type (2015-2020)
• 9.3 Japan Cancer Genome Sequencing Market Size by Application (2015-2020)
• 9.4 Japan Cancer Genome Sequencing Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Cancer Genome Sequencing Market Size (2015-2026)
• 10.2 Southeast Asia Cancer Genome Sequencing Market Size by Type (2015-2020)
• 10.3 Southeast Asia Cancer Genome Sequencing Market Size by Application (2015-2020)
• 10.4 Southeast Asia Cancer Genome Sequencing Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Agilent Technologies
  • 11.1.1 Agilent Technologies Company Details
  • 11.1.2 Agilent Technologies Business Overview
  • 11.1.3 Agilent Technologies Cancer Genome Sequencing Introduction
  • 11.1.4 Agilent Technologies Revenue in Cancer Genome Sequencing Business (2015-2020))
  • 11.1.5 Agilent Technologies Recent Development
• 11.2 GE Healthcare Life Sciences
  • 11.2.1 GE Healthcare Life Sciences Company Details
  • 11.2.2 GE Healthcare Life Sciences Business Overview
  • 11.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Introduction
  • 11.2.4 GE Healthcare Life Sciences Revenue in Cancer Genome Sequencing Business (2015-2020)
  • 11.2.5 GE Healthcare Life Sciences Recent Development
• 11.3 Johnson & Johnson
  • 11.3.1 Johnson & Johnson Company Details
  • 11.3.2 Johnson & Johnson Business Overview
  • 11.3.3 Johnson & Johnson Cancer Genome Sequencing Introduction
  • 11.3.4 Johnson & Johnson Revenue in Cancer Genome Sequencing Business (2015-2020)
  • 11.3.5 Johnson & Johnson Recent Development
• 11.4 LI-COR Biosciences
  • 11.4.1 LI-COR Biosciences Company Details
  • 11.4.2 LI-COR Biosciences Business Overview
  • 11.4.3 LI-COR Biosciences Cancer Genome Sequencing Introduction
  • 11.4.4 LI-COR Biosciences Revenue in Cancer Genome Sequencing Business (2015-2020)
  • 11.4.5 LI-COR Biosciences Recent Development
• 11.5 Abbott Laboratories
  • 11.5.1 Abbott Laboratories Company Details
  • 11.5.2 Abbott Laboratories Business Overview
  • 11.5.3 Abbott Laboratories Cancer Genome Sequencing Introduction
  • 11.5.4 Abbott Laboratories Revenue in Cancer Genome Sequencing Business (2015-2020)
  • 11.5.5 Abbott Laboratories Recent Development
• 11.6 Beckman Coulter
  • 11.6.1 Beckman Coulter Company Details
  • 11.6.2 Beckman Coulter Business Overview
  • 11.6.3 Beckman Coulter Cancer Genome Sequencing Introduction
  • 11.6.4 Beckman Coulter Revenue in Cancer Genome Sequencing Business (2015-2020)
  • 11.6.5 Beckman Coulter Recent Development
• 11.7 Bayer
  • 11.7.1 Bayer Company Details
  • 11.7.2 Bayer Business Overview
  • 11.7.3 Bayer Cancer Genome Sequencing Introduction
  • 11.7.4 Bayer Revenue in Cancer Genome Sequencing Business (2015-2020)
  • 11.7.5 Bayer Recent Development
• 11.8 Hamilton Thorne Biosciences
  • 11.8.1 Hamilton Thorne Biosciences Company Details
  • 11.8.2 Hamilton Thorne Biosciences Business Overview
  • 11.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Introduction
  • 11.8.4 Hamilton Thorne Biosciences Revenue in Cancer Genome Sequencing Business (2015-2020)
  • 11.8.5 Hamilton Thorne Biosciences Recent Development
• 11.9 Integrated DNA Technologies
  • 11.9.1 Integrated DNA Technologies Company Details
  • 11.9.2 Integrated DNA Technologies Business Overview
  • 11.9.3 Integrated DNA Technologies Cancer Genome Sequencing Introduction
  • 11.9.4 Integrated DNA Technologies Revenue in Cancer Genome Sequencing Business (2015-2020)
  • 11.9.5 Integrated DNA Technologies Recent Development
• 11.10 Microchip Biotechnologies
  • 11.10.1 Microchip Biotechnologies Company Details
  • 11.10.2 Microchip Biotechnologies Business Overview
  • 11.10.3 Microchip Biotechnologies Cancer Genome Sequencing Introduction
  • 11.10.4 Microchip Biotechnologies Revenue in Cancer Genome Sequencing Business (2015-2020)
  • 11.10.5 Microchip Biotechnologies Recent Development
• 11.11 Myriad Genetics
  • 10.11.1 Myriad Genetics Company Details
  • 10.11.2 Myriad Genetics Business Overview
  • 10.11.3 Myriad Genetics Cancer Genome Sequencing Introduction
  • 10.11.4 Myriad Genetics Revenue in Cancer Genome Sequencing Business (2015-2020)
  • 10.11.5 Myriad Genetics Recent Development
• 11.12 Commonwealth Biotechnologies
  • 10.12.1 Commonwealth Biotechnologies Company Details
  • 10.12.2 Commonwealth Biotechnologies Business Overview
  • 10.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Introduction
  • 10.12.4 Commonwealth Biotechnologies Revenue in Cancer Genome Sequencing Business (2015-2020)
  • 10.12.5 Commonwealth Biotechnologies Recent Development
• 11.13 ZS Genetics
  • 10.13.1 ZS Genetics Company Details
  • 10.13.2 ZS Genetics Business Overview
  • 10.13.3 ZS Genetics Cancer Genome Sequencing Introduction
  • 10.13.4 ZS Genetics Revenue in Cancer Genome Sequencing Business (2015-2020)
  • 10.13.5 ZS Genetics Recent Development
• 11.14 Pacific Biosciences
  • 10.14.1 Pacific Biosciences Company Details
  • 10.14.2 Pacific Biosciences Business Overview
  • 10.14.3 Pacific Biosciences Cancer Genome Sequencing Introduction
  • 10.14.4 Pacific Biosciences Revenue in Cancer Genome Sequencing Business (2015-2020)
  • 10.14.5 Pacific Biosciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer